Figure 3.
Summary of the key results from each step on the Next-Generation Risk Assessment case study workflow (see Figure 1) for 0.1% coumarin in face cream and body lotion. Abbreviations: HTTr, high-throughput transcriptomics; MoS, margin of safety; PBK, physiologically based kinetic; PoD, point of departure.